7/31/2007

The FDA has expressed concern over possible fatal side effects from the use of Tysabri to treat Crohn's disease. The agency says it is concerned that taking Tysabri, already approved for multiple sclerosis, could lead to a rare and incurable nervous system disease.

Related Summaries